PT  - JOURNAL ARTICLE
AU  - Riccardo Gallotti
AU  - Francesco Valle
AU  - Nicola Castaldo
AU  - Pierluigi Sacco
AU  - Manlio De Domenico
TI  - Assessing the risks of “infodemics” in response to COVID-19 epidemics
AID  - 10.1101/2020.04.08.20057968
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.08.20057968
4099  - http://medrxiv.org/content/early/2020/04/16/2020.04.08.20057968.short
4100  - http://medrxiv.org/content/early/2020/04/16/2020.04.08.20057968.full
AB  - Our society is built on a complex web of interdependencies whose effects become manifest during extraordinary events such as the COVID-19 pandemic, with shocks in one system propagating to the others to an exceptional extent. We analyzed more than 100 millions Twitter messages posted worldwide in 64 languages during the epidemic emergency due to SARS-CoV-2 and classified the reliability of news diffused. We found that waves of unreliable and low-quality information anticipate the epidemic ones, exposing entire countries to irrational social behavior and serious threats for public health. When the epidemics hit the same area, reliable information is quickly inoculated, like antibodies, and the system shifts focus towards certified informational sources. Contrary to mainstream beliefs, we show that human response to falsehood exhibits early-warning signals that might be mitigated with adequate communication strategies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe dataset analyzed in this paper can be interactively visualized and accessed at https://covid19obs.fbk.eu/ https://osf.io/n6upx/